Drug Database
Back to search

Poland· PL-100047530

Nitrazepam GSK

A nitrazepam product containing nitrazepamum, registered in Poland by GSK PSC Poland Sp. z o.o.. The same ATC class is registered in 12 of our 19 countries.

ATC N05CD02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedNitrazepam GSKATCN05CD02REGISTER NO.PL-100047530PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about nitrazepamumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Nitrazepam is registered in 12 of 19 countries.

Countries holding a registration under ATC N05CD02 (nitrazepam), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose
Search nitrazepam products by name

Nitrazepam · ATC N05CD02

12 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of nitrazepam costs, country by country.

Normalised to the WHO defined daily dose (5 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Nitrazepam · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.88
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Nitrazepamum
Manufacturer
GSK PSC Poland Sp. z o.o.
Country
Poland (PL)
ATC code
N05CD02
ATC class
Nitrazepam
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990148912

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

125 interactions on record for nitrazepam.

Graded by severity as the source publishes them — 81 info. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check nitrazepam against other medicinesHow interaction checks work

Nitrazepam · interactions on record

125 records

  • 81 info

Most severe, free to view

    44 more interactions with mechanism and management, from a commercially licensed source.

    Sign in to check
    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same medicine, other countries

    Nitrazepam in 9 other countries

    What each register calls a product with the same active substance — salts and hydrates count as the same.

    All nitrazepam products

    Authorised across Europe · EMA

    The same active substance is authorised in 19 EEA countries. Names it is sold under:

    • Austria · Mogadon
    • Belgium · Mogadon
    • Cyprus · Nitredon
    • Germany · Mogadan, Nitrazepam Al
    • Denmark · Nitrazepam "dak", Nitrazepam Accord
    • Estonia · Nitrazepam Accord
    • Finland · Nitrazepam Accord
    • France · Mogadon
    • United Kingdom (Northern Ireland) · Mogadon, Nitrazepam Accord-Uk
    • Croatia · Cerson
    • Hungary · Eunoctin, Eunoctin Mini
    • Italy · Mogadon
    • Lithuania · Eunoctin
    • Luxembourg · Mogadon
    • Malta · Mogadon, Nitredon
    • Netherlands · Nitrazepam Aurobindo
    • Norway · Apodorm
    • Romania · Nitrazepam Lph Labormed, Nitrazepam Richter
    • Slovenia · Cerson

    Source: European Medicines Agency, Article 57 product data.

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/1ed58900-b2ae-4542-8b3b-84669ba349e5
GET /v1/drugs/1ed58900-b2ae-4542-8b3b-84669ba349e5?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "form": "Tabletki",
  "source": "urpl",
  "strength": "5 mg",
  "packaging": "05909990148912 ¦ Rp ¦ 7109\n20 tabl.",
  "substance": "Nitrazepamum 5 mg",
  "common_name": "Nitrazepamum",
  "pl_product_id": "100047530",
  "pozwolenie_nr": "01489",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
    API referenceMCP serverPlans

    See everything about nitrazepam.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console